Skip to content Skip to menu

Medicines Australia welcomes appointment of Dr John Skerritt as TGA National Manager

Friday, 4 May 2012

Media Release

Medicines Australia chief executive Dr Brendan Shaw today welcomed the appointment of Dr John Skerritt as the new National Manager of the Therapeutic Goods Administration.

Dr Shaw said Medicines Australia looks forward to working with Dr Skerritt on a range of regulatory issues.

“Medicines Australia has established a productive relationship with the TGA and we are committed to continuing as a key partner in the implementation of the TGA reform agenda,” Dr Shaw said.

“Dr Skerritt is an extremely experienced and well regarded scientist who is well placed to lead the TGA’s ambitious and important program of business process reforms that are underway.

“There is still much important work to be undertaken, particularly with regard to the Blueprint for reform and the Australia New Zealand Therapeutic Products Agency.

“I look forward to engaging constructively with Dr Skerritt on these and other issues.”

-ENDS-

Contact Person:

Jamie Nicholson
Media Communications Manager
Phone: 0419 220 293
Email:
Jamie.Nicholson@medicinesaustralia.com.au

Information

As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at medicinesaustralia.com.au/covid-19/

Top